Chao Cai

1.3k total citations
43 papers, 1.0k citations indexed

About

Chao Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chao Cai has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Chao Cai's work include Prostate Cancer Treatment and Research (11 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer, Lipids, and Metabolism (6 papers). Chao Cai is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer, Lipids, and Metabolism (6 papers). Chao Cai collaborates with scholars based in China, United States and Macao. Chao Cai's co-authors include Weide Zhong, Zhaodong Han, Huichan He, Qi-Shan Dai, Xiaolu Duan, Yuxiang Liang, Guohua Zeng, Funeng Jiang, Tuo Deng and Xin Fu and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Chao Cai

42 papers receiving 1.0k citations

Peers

Chao Cai
Yiqian Liu China
Chenyang Ye China
Garrett Daniels United States
Yuxi Zhu China
Tianbo Xu China
Erjie Xia China
Shuduo Xie China
Ziguang Song China
Lacey M. Litchfield United States
Youngtae Jeong United States
Yiqian Liu China
Chao Cai
Citations per year, relative to Chao Cai Chao Cai (= 1×) peers Yiqian Liu

Countries citing papers authored by Chao Cai

Since Specialization
Citations

This map shows the geographic impact of Chao Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Cai more than expected).

Fields of papers citing papers by Chao Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Cai. The network helps show where Chao Cai may publish in the future.

Co-authorship network of co-authors of Chao Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Cai. A scholar is included among the top collaborators of Chao Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Cai. Chao Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Jianming, Jiaqi Liang, Gang Xiao, et al.. (2024). Cathepsin L in Lung Adenocarcinoma: Prognostic Significance and Immunotherapy Response Through a Multi Omics Perspective. Cancer Informatics. 23. 2683934052–2683934052. 1 indexed citations
2.
Zhong, Chuanfan, Jianming Lü, Zining Long, et al.. (2024). GG-NER’s role in androgen receptor signaling inhibitor response for advanced prostate cancer. Cell Communication and Signaling. 22(1). 600–600. 2 indexed citations
3.
4.
Liang, Yingke, Hongwei Luo, Chuanfan Zhong, et al.. (2023). N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer. Human Genetics. 143(7). 857–874. 2 indexed citations
5.
Mazzon, Giorgio, Caterina Gregorio, Jiehui Zhong, et al.. (2023). Design and internal validation of S.I.C.K.: a novel nomogram predicting infectious and hemorrhagic events after percutaneous nephrolithotomy. Minerva Urology and Nephrology. 75(5). 625–633. 5 indexed citations
6.
7.
Cai, Chao, Zezhen Liu, Xiangkun Wu, et al.. (2021). Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer. Genetic Testing and Molecular Biomarkers. 25(2). 131–139. 8 indexed citations
8.
Duan, Xiaolu, Zhenzhen Kong, Xin Mai, et al.. (2018). Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney. Redox Biology. 16. 414–425. 69 indexed citations
9.
Zhong, Di, Huijian Zhang, Yaodong Jiang, et al.. (2016). Saikosaponin-d: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes. Biochemical and Biophysical Research Communications. 474(4). 722–729. 32 indexed citations
10.
Duan, Xiaolu, Tao Zhang, Zhenzhen Kong, et al.. (2016). β-arrestin1 promotes epithelial-mesenchymal transition via modulating GSK-3β/β-catenin pathway in prostate cancer cells. Biochemical and Biophysical Research Communications. 479(2). 204–210. 21 indexed citations
11.
Cai, Chao, Zhaodong Han, Yanqiong Zhang, et al.. (2015). miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. Clinical Cancer Research. 21(21). 4922–4934. 103 indexed citations
12.
Zeng, Yanru, Zhaodong Han, Cong Wang, et al.. (2015). Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer. BMC Urology. 15(1). 90–90. 42 indexed citations
13.
Cornejo, Kristine M., Min Lu, Ping Yang, et al.. (2015). Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma. Human Pathology. 46(6). 820–826. 28 indexed citations
14.
Liang, Yuxiang, Rujun Mo, Huichan He, et al.. (2015). Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer. Oncology Reports. 33(5). 2648–2654. 7 indexed citations
15.
Zou, Jun, Zhaodong Han, Liang Zhou, et al.. (2014). Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer. Medical Oncology. 32(1). 373–373. 24 indexed citations
16.
Huang, Yaqiang, Zhaodong Han, Yuxiang Liang, et al.. (2013). Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer. Medical Oncology. 31(1). 820–820. 43 indexed citations
17.
Dai, Qi-Shan, Huichan He, Chao Cai, et al.. (2011). [Multicenter case-control study of the relationship between smoking and bladder cancer in China].. PubMed. 91(34). 2407–10. 6 indexed citations
18.
Cai, Chao, Funeng Jiang, Yuxiang Liang, et al.. (2011). Classical and Alternative Nuclear Factor-κB Pathways: A Comparison among Normal Prostate, Benign Prostate Hyperplasia and Prostate Cancer. Pathology & Oncology Research. 17(4). 873–878. 6 indexed citations
19.
He, Huichan, Jiahong Chen, Chao Cai, et al.. (2011). Expression of Hedgehog Pathway Components is Associated with Bladder Cancer Progression and Clinical Outcome. Pathology & Oncology Research. 18(2). 349–355. 42 indexed citations
20.
Chen, Jia‐Hong, et al.. (2011). Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population. Medical Oncology. 29(3). 1972–1984. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiqian Liu Breakdown of academic impact, for papers by Chenyang Ye Breakdown of academic impact, for papers by Garrett Daniels Breakdown of academic impact, for papers by Yuxi Zhu Breakdown of academic impact, for papers by Tianbo Xu Breakdown of academic impact, for papers by Erjie Xia Breakdown of academic impact, for papers by Shuduo Xie Breakdown of academic impact, for papers by Ziguang Song Breakdown of academic impact, for papers by Lacey M. Litchfield Breakdown of academic impact, for papers by Youngtae Jeong
Rankless by CCL
2026